Drug alert: 35 drug samples fail to clear CDSCO test, 1 declared spurious
In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 35 medicine batches for failing to qualify for random drug sample tests for the month of April, while one drug sample has been declared spurious.
These drugs samples which are declared not of standard quality include Skymap Pharmaceuticals' Metopal – 50 XL (Metoprolol Succinate Extended Release Tablets IP), Alkem Health Science's Pantoprazole gastro- resistant and domperidone prolonged-release capsules IP Pan-D, Zee laboratories' Paracetamol oral suspension IP 60 ml. (for Paediatric use), Hindustan Antibiotic's Diclofenac Sodium Injection and others.
For more details, check out the link given below:
Drug alert:35 Drug Samples Fail To Clear CDSCO Test, 1 Declared spurious
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.